← Open Payments lookup

MARK BRYAN TING: Open Payments

NPI 1588925861 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,849 in 67 payments from 11 companies in 2025. Trend: 2023 $715 · 2024 $1,132 · 2025 $1,849

Food & beverage: $1,658Education: $191
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.18$427
Alkermes, Inc.11$326
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$252
Janssen Pharmaceuticals, Inc9$211
Teva Pharmaceuticals USA, Inc.3$200
E.R. Squibb & Sons, L.L.C.6$174
VERTEX PHARMACEUTICALS INCORPORATED1$98
ABBVIE INC.3$81
Otsuka America Pharmaceutical, Inc.1$29
Neurocrine BioSciences, Inc.1$28

Products named: FANAPT, CAPLYTA, ARISTADA, INVEGA SUSTENNA, COBENFY, LYBALVI, JOURNAVX, VRAYLAR.

Industry payments across CA — which companies pay providers there.